WHO Public Assessment Reports (WHOPARs) published
M
Newly prequalified Active Pharmaceutical Ingredient (API)
M
Ethionamide (WHOAPI-422) manufactured by Micro Labs Limited, has
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
M
The following API was added:
Newly prequalified Active Pharmaceutical Ingredient (API)
M
Oseltamivir (phosphate) (WHOAPI-421) manufactured by Shanghai Desano Chemical Pharmaceu
Two PQT Medicines trainings for regulators in 2023
M
The 15th Annual Prequalification Team: Medicines (PQT/MED) Quality Assessment Training will be a virtual workshop that will take place on Monday, 5 June through Thursday, 8 June 2023.